Products & Reviews

A transformative imaging solution that enables comprehensive analysis of cellular phenotypes and their interrelationships.

The next-generation mass cytometer, CyTOF XT™, redefines high-parameter cytometry with advances in automation, throughput, time to results and total cost of ownership. Built to simplify the design and execution of deep cell profiling studies, CyTOF XT standardizes sample analysis with reproducible workflows and automation to accelerate novel therapeutic development and improve human health.

Maintain sample identity throughout the workflow  

Targeted NGS library preparation, gene expression and genotyping. Increase productivity and efficiency with automated, cost-effective, and easy-to-use workflows for targeted DNA next-generation sequencing (NGS) library preparation, gene expression analysis and genotyping by allele-specific PCR.

Automated platform for single-cell omics and multi-omic research using solid-state microfluidics. C1 with integrated fluidic circuits (IFCs) enables the preparation of single-cell templates for total RNA sequencing and multi-omic applications such as preparing mRNA and DNA and mRNA and protein from the same isolated and imaged single cell.

Transform your laboratory productivity with nanoscale automation delivering substantial cost and operational savings for RNA-Seq library preparation.

Confidently analyze multiple somatic variants with a flexible, automated NGS workflow

Bioinformatics and Protein Array Services

Profiling against cancer antigens. Using the CTA Protein Array, Sengenics can quantify autoantibodies against more than 200 clinically relevant cancer testis antigens. These are tumor antigens normally expressed in germ cells but not in adult somatic tissues. In cancers, this regulation can be disrupted, resulting in CTA expression in tumors. The CTA array is ideal for research related to cancer immunotherapy.

The future of spatial biology is here

Autoimmune disease autoantibody screening. Using the Pan-Autoimmune Protein Array 1.0, Sengenics can screen autoantibodies against more than 100 clinically relevant antigens in a wide range of autoimmune diseases. The Pan-Autoimmune Protein Array 1.0 service is ideal for focused autoimmune disease research.